<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian journal of Pediatric Hematology and Oncology</title>
<title_fa>Iranian journal of Pediatric Hematology and Oncology</title_fa>
<short_title>Iran J Ped Hematol Oncol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijpho.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-8892</journal_id_issn>
<journal_id_issn_online>2228-6993</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>15</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Prevalence, Disease Manifestations and Outcomes of Paediatric Sickle Cell Anaemia in Calabar, Nigeria: A Single Center 6-Year Review</title>
	<subject_fa>هماتولوژی</subject_fa>
	<subject>Hematology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;border:double windowtext 1.5pt; padding:1.0pt 4.0pt 1.0pt 4.0pt&quot;&gt;&lt;/div&gt;
&lt;div style=&quot;border: 1.5pt double windowtext; padding: 1pt 4pt; text-align: justify;&quot;&gt;&lt;span style=&quot;font-family:Tahoma;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The burden of sickle cell anaemia (SCA) is worsening globally. Recognition of paediatric SCA burden is vital to comprehending the overall SCA burden. Aim was to determine the prevalence, disease manifestations and outcomes of paediatric SCA. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;It was a retrospective study of all children with SCA, 0.5 year (6months) - 17 years old, managed from 2018 through 2023. Data obtained were sex, age at first visit per year, diagnoses and date per visit, location (clinics or emergency-room) of visit, intervals between visits, and death. Disease manifestations per subject were summarized into diagnosis while default was defined as &gt;3 months visit interval.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results: &lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:10.0pt&quot;&gt;Of the 532 subjects, 55.6% were males with overall median (interquartile [IQR]) age on first visit of 9 (5 - 13) years. On average, paediatric SCA constituted 4% of first visits per year. There were 252 sick visits per year, 544 diagnoses per year and 146 hospitalisations per year. Commonest diagnosis in emergency-room and clinics were bone pain crises (46.2%) and steady-state (48.5%), respectively. The 11 - 17-year-olds were more likely to have bone pain crises than 0.5 - 4-year-olds (Odds Ratio [OR] 0.381; 95%CI:&lt;b&gt; &lt;/b&gt;0.487-0.787) and 5 - 9-year-olds (OR 0.298; 95%CI:&lt;b&gt; &lt;/b&gt;0.573-0.861). They were also more likely to have avascular necrosis than the 0.5 - 4-year-olds (OR 0.789; 95%CI:&lt;b&gt; &lt;/b&gt;0.047-0.938) and 5 - 9-year-olds (OR 0.777; 95%CI:&lt;b&gt; &lt;/b&gt;0.064-0.781). Overall median (IQR) default time was 6 (5 - 7) months with more defaults (85.1%) than compliants (14.9%) (p&lt;0.001) while 0.56% died. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion: &lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:10.0pt&quot;&gt;The overall prevalence of Paediatric SCA in the region is 4% with approximately one hospitalisation per sick visit and more than one diagnoses per visit. There is a high default rate but a low mortality rate (0.56%). Sustained improvement in the management of SCA, from childhood through adulthood, may help alleviate the increasing burden of the condition.&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Morbidity, Mortality, Paediatric, Prevalence, Sickle cell</keyword>
	<start_page>440</start_page>
	<end_page>455</end_page>
	<web_url>http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-1167-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Anthony</first_name>
	<middle_name></middle_name>
	<last_name>Nlemadim</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>tonynlemas@yahoo.com</email>
	<code></code>
	<orcid>0000-0003-0095-8975</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation>
	<affiliation_fa>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Jacintha</first_name>
	<middle_name></middle_name>
	<last_name>Okoi-obuli</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>okoiobulijacintha@gmail.com</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation>
	<affiliation_fa>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Elizabeth</first_name>
	<middle_name></middle_name>
	<last_name>Nkanga</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>bettienkanga@gmail.com</email>
	<code></code>
	<orcid>0000-0002-7178-1567</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Calabar Children&#039;s Eye Centre, Department of Ophthalmology, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Calabar Children&#039;s Eye Centre, Department of Ophthalmology, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Chimaeze</first_name>
	<middle_name></middle_name>
	<last_name>Torty</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>chimaezetorty@unical.edu.ng</email>
	<code></code>
	<orcid>0000-0002-3288-802X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Neurology unit, Department of Paediatrics, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Neurology unit, Department of Paediatrics, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Kingsley</first_name>
	<middle_name></middle_name>
	<last_name>Akaba</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>akaba_kingsley@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-4573-1187</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Haematology, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Department of Haematology, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Juliet</first_name>
	<middle_name></middle_name>
	<last_name>Venn</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>odyvenn04@yahoo.co.uk</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Children emergency room, Department of Paediatrics, UCTH, Calabar, Nigeria</affiliation>
	<affiliation_fa>Children emergency room, Department of Paediatrics, UCTH, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Kelechi</first_name>
	<middle_name></middle_name>
	<last_name>Uhegbu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>kelechi4u2001@gmail.com</email>
	<code></code>
	<orcid>0000-0002-1668-8386</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Gastroenterology unit, Department of Paediatrics, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Gastroenterology unit, Department of Paediatrics, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Sunday</first_name>
	<middle_name></middle_name>
	<last_name>Okonkwo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>okosund@yahoo.com</email>
	<code></code>
	<orcid>0000-0003-1909-0600</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Ophthalmology, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Department of Ophthalmology, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Grace</first_name>
	<middle_name></middle_name>
	<last_name>Nwankwo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drgracenwankwo@gmail.com</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation>
	<affiliation_fa>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Ofonime</first_name>
	<middle_name></middle_name>
	<last_name>Essien</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ofonimessien29@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-3111-740X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Haematology, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Department of Haematology, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Glory</first_name>
	<middle_name></middle_name>
	<last_name>Bassey</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>globass75@gmail.com</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Respiratory unit, Department of Paediatrics, University of Calabar, Calabar, Nigeria</affiliation>
	<affiliation_fa>Respiratory unit, Department of Paediatrics, University of Calabar, Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Friday</first_name>
	<middle_name></middle_name>
	<last_name>Odey</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>faodey@gmail.com</email>
	<code></code>
	<orcid>0000-0003-1066-5631</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation>
	<affiliation_fa>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation_fa>
	 </author>


	<author>
	<first_name>Martin</first_name>
	<middle_name></middle_name>
	<last_name>Meremikwu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mmeremiku@gmail.com</email>
	<code></code>
	<orcid>0000-0002-6144-9413</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation>
	<affiliation_fa>Haematology-Oncology unit, Department of Paediatrics, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
